-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III

Symposia: Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Yannis K. Valtis, MD1, Yael Flamand, MS2*, Shai Shimony, MD3*, Andrew E. Place, MD, PhD4, Lewis B. Silverman, MD5, Lynda M. Vrooman, MD2*, Andrew M. Brunner, MD6, Stephen E. Sallan, MD2, Martha Wadleigh, MD2, Jacqueline S. Garcia, MD3, Eric S. Winer, MD2, Ilene Galinsky, ANP3, Julie Bergeron, MD7, Julie Asch, MD8, Matthew D. Seftel, MD, FRCP, FRCPC, MPH9, Richard M Stone, MD2, Marlise R. Luskin, MD10 and Daniel J. DeAngelo2

1Memorial Sloan Kettering Cancer Center, New York, NY
2Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
4Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
5Dana-Farber Cancer Institute, Boston Children’s Hospital, Boston, MA
6Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
7Hôpital Maisonneuve-Rosemont, CIUSSS EMTL, Montreal, QC, CAN
8Intermountain Health, Salt Lake City, UT
9Department of Medicine, University of British Columbia, Vancouver, CAN
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Jose Tinajero, PharmD1*, Sharon Xu, PharmD1*, Tina Nguyen2*, Dat Ngo, PharmD3*, Anthony Stein, MD4, Paul B. Koller, MD4, Vaibhav Agrawal, M.D.5, Hoda Pourhassan, MD6, Vinod Pullarkat, MD1 and Ibrahim Aldoss, MD1

1City of Hope, Duarte, CA
2City of Hope Medical Center, Duarte, CA
3Pharmacy, City of Hope National Medical Center, DUARTE, CA
4Hematology/HCT, City of Hope National Medical Center, Duarte, CA
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
6Hematology/HCT, City of Hope, Duarte, CA

Brandon Dasilva, MD1, Rutu D. Vyas, CRA2*, Alicia Darwin, MD1*, Kathryn Russel, ARNP3*, Jason Gilbert, MD4*, Virginia Tan, MD5*, Himani Darji, MBBS, MPH6*, Katharine Miller, PhD, MPH6*, Emily C Liang, MD2,7, Suravi Raychaudhuri, MD2,8, Adam S. Duvall, MD, MPH9, Michaela Liedtke, MD10, Wendy Stock, MD11, Ryan D Cassaday, MD2, Marc Schwartz, MD12*, Jessica T. Leonard, MD13, Marlise R. Luskin, MD14 and Lori S. Muffly, MD15

1Department of Medicine, Stanford University School of Medicine, Stanford, CA
2Fred Hutchinson Cancer Center, Seattle, WA
3University of Washington School of Medicine, Seattle, WA
4Department of Medicine, University of Colorado School of Medicine, Aurora, CO
5Department of Medicine, Oregon Health & Science University, Portland, OR
6Stanford University School of Medicine, Stanford, CA
7University of Washington, Seattle, WA
8Department of Medicine, University of Washington, Davis, CA
9Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
10Stanford Cancer Center, Palo Alto, CA
11Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
12Division of Hematology, University of Colorado, Aurora, CO
13Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR
14Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
15Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA

Yang Zhou1,2*, Junjie Chen2*, Cai Zihong3*, Qifa Liu, MD4 and Hongsheng Zhou5,6*

1Southern Medical University, Guangzhou, China
2Nanfang Hospital, Guangzhou, China
3Nanfang Hospital, Southern Medical University,, Guangzhou, CHN
4Department of Hematology, Nanfang Hospital, Southern medical university CN, Guangzhou, China
5Nanfang Hospital, Southern Medical University, Guangzhou, China
6Nanfang Hospital, Southern Medical University, Guangzhou, CHN

Guru Subramanian Guru Murthy, MBBS1, Bijal D. Shah, MD2, Adam S Duvall, MD3, Jessica T. Leonard, MD4, Talha Badar, MD5, Cecilia Y. Arana Yi, MD6, Tyce Kearl, MD7*, Arielle Baim8*, Alexandra M. Harrington, MD, MT(ASCP)8, Aniko Szabo, PhD8* and Ehab L. Atallah, MD9

1Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
3Department of Medicine, University of Chicago, Chicago, IL
4Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR
5Mayo Clinic, Jacksonville, FL
6Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
7Division of Hematology/Oncology, Medical College of Wisconsin, MIlwaukee, WI
8Medical College of Wisconsin, Milwaukee, WI
9Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI

Jing Lu, MD1*, Ying Wang2*, Huiying Qiu3*, Xin Zhou4*, Xuzhang Lu5*, Miao Miao6*, Bin Gu7*, Xiaohui Hu7*, Depei Wu6 and Suning Chen7*

1Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, AL, China
2National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
3Department of Hematology, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
4Department of Hematology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China
5Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, China
6The First Affiliated Hospital of Soochow University, Suzhou, China
7Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China

Jasmeet Sidhu, MD1,2,3*, Arijit Chakraborty4*, Parag Das4*, Manash Pratim Gogoi4*, Tanima Dey4*, Fabio D. Steffen, PhD5*, Sangramjit Basu4*, Debdutta Ganguli4*, Debjani Ghosh1*, Niharendu Ghara6*, Subhajit Kundu4*, Abhirupa Kar4*, Beat Bornhauser, PhD5*, Jean-Pierre Bourquin, MD, PhD7, Vaskar Saha, PhD, FRCP, FRCPath1,3,8* and Shekhar Krishnan1,3,8*

1Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India
2University Children’s Hospital, Zurich, Switzerland
3Tata Translational Cancer Research Center, Tata Medical Center, Kolkata, India
4Tata Translational Cancer Research Center, Kolkata, India
5Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland
6Department of Paediatric Haematology and Oncology, Tata Medical Center, Zurich, India
7Department of Oncology and Children’s Research Center, University Children's Hospital Zurich, Zurich, Switzerland
8Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health,, University of Manchester, Manchester, United Kingdom

Daniel Nguyen, MD, PhD1, Hagop M. Kantarjian, MD2, Nicholas J. Short, MD2, Nitin Jain, MD3, Fadi G. Haddad, MD2*, Musa Yilmaz, MD2*, Alessandra Ferrajoli, MD2, Tapan M. Kadia, MD2, Yesid Alvarado Valero, MD2, Abhishek Maiti, MD4, Cedric Nasnas2*, Lewis Nasr2*, Rebecca Garris2*, Marina Y. Konopleva2, Farhad Ravandi, MD, MBBS2 and Elias Jabbour2

1University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
4Department of Leukemia, MD Anderson Cancer Center, Houston, TX

Fanny Alby Laurent, MD, PhD1*, Amani Ouedrani, MD2*, Pierre Jatteau, MD1*, Marion Strullu, MD, PhD3*, Claire Montlahuc, MD4*, Chaima Mrad, MD1*, Audrey Guilmatre, PhD1*, Maxime Ferreboeuf, PhD1*, Anne-France Ray-Lunven, MD3*, Florentia Kaguelidou, MD, PhD3*, Lucienne Chatenoud, MD5*, Laurence Morand-Joubert, MD, PhD6*, Sylvie Chevret, MD, PhD7* and Arnaud Petit, MD, PhD1,8*

1Hôpital Armand Trousseau, APHP, Paris, France
2Hopital Necker-Enfants-Malades, APHP, Paris, France
3Hôpital Robert Debré, APHP, Paris, France
4Unité de Recherche Clinique (URC) Saint-Louis Lariboisière Fernand-Widal, Hôpital Saint Louis, APHP, Paris, France
5Université Paris Cité, Paris, France
6Hôpital Saint-Antoine, APHP, Paris, France
7Hôpital Saint Louis, APHP, Paris, FRA
8Sorbonne Université, Paris, France

Marc Schwartz, MD1*, Christine M. McMahon2, Maria L Amaya, MD, PhD1, Matthew Witkowski, PhD2, Daniel A. Pollyea, MD2*, Jonathan A Gutman, MD3, Mohd Minhajuddin, PhD4*, Clayton Smith, MD3 and Craig T. Jordan, PhD2

1Division of Hematology, University of Colorado, Aurora, CO
2University of Colorado School of Medicine, Aurora, CO
3University of Colorado, Aurora, CO
4University of Colorado, Anschutz Medical Campus, Aurora, CO

Yannis K. Valtis, MD1, Mark Blaine Geyer, MD2, Martina Torres3*, Mackenzie Grogan3*, Madhulika Shukla4*, Eytan M. Stein5 and Jae H. Park, MD1

1Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan Kettering Cancer Center, New York
4Memorial Sloan-Kettering Cancer Center, New York, NY
5Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY

Sabina Chiaretti, MD, PhD1, Matteo Leoncin, MD2*, Loredana Elia3*, Alfonso Piciocchi4*, Mabel Matarazzo3*, Mariangela Di Trani, Bachelor in Science3*, Simona Sica5*, Mario Luppi, MD6*, Valentina Mancini, MD7*, Erika Borlenghi, MD8*, Silvia Imbergamo9*, Carmine Selleri, MD10, Giuseppe Visani11*, Bruno Martino, MD12*, Daniele Vallisa, MD13*, Calogero Vetro, MD14*, Stefano Soddu15*, Monica Messina, PhD15*, Paola Fazi, MD15*, Alessandro Rambaldi, M.D.16 and Robin Foà, MD3*

1Division of Hematology, Department of Translational and Precision Medicine, Division of Hematology, Rome, Italy
2Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia-Mestre, Italy
3Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
4GIMEMA Foundation, Rome, Italy
5Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
6Hematology Unit and Chair, Department of Medical and Surgical Sciences, Azienda Ospedaliera Universitaria di Modena, University of Modena and Reggio Emilia, Modena, Italy
7Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
8Hematology, ASST Spedali Civili, Brescia, Italy
9Department of Medicine, Hematology and Clinical Immunology Unit,, University of Padova, Padova, Italy
10Department of Medicine and Surgery, Hematology, University Hospital San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy
11Hematology and Stem Cell Transplantation, AORMIN, Pesaro, Italy
12Hematology Unit, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy
13Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy
14Division of hematology, A.O.U. Policlinico G.Rodolico – S. Marco, Catania, Italy
15GIMEMA Foundation, Data Center and Health Outcomes Research Unit, Rome, Italy
16Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy

Robin Foà, MD1*, Renato Bassan2*, Loredana Elia1*, Alfonso Piciocchi, MS3*, Stefano Soddu3*, Monica Messina, PhD3*, Felicetto Ferrara, MD4*, Monia Lunghi, MD, PhD5*, Antonino Mulè, MD6*, Massimiliano Bonifacio, MD7*, Nicola Fracchiolla, MD8*, Prassede Salutari9*, Paola Fazi, MD3*, Anna Guarini, PhD1*, Alessandro Rambaldi, M.D.10 and Sabina Chiaretti, MD, PhD11

1Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
2Hematology Unit, Dell'Angelo Hospital, Mestre-Venezia, Italy
3GIMEMA Foundation, Data Center and Health Outcomes Research Unit, Rome, Italy
4Divisione di Ematologia, Ospedale Cardarelli, Napoli, Italy
5Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
6UOC di Oncoematologia,, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
7Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy
8Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
9Ospedale Civico Spirito Santo, Lanciano, Italy
10Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
11Division of Hematology, Department of Translational and Precision Medicine, Division of Hematology, Rome, Italy

Richard B. Lock, PhD1, Cara E Toscan1*, Hannah McCalmont1*, Kathryn Evans1*, Louise Doculara1*, Hansen J Kosasih1*, Andrew J Gifford1,2*, Amir Ashoorzadeh3*, Xiaojing Lin3*, Toby N Trahair1,4*, Charles E De Bock1*, Adam V Patterson3* and Jeff B Smaill3*

1Children’s Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, NSW, Australia
2Anatomical Pathology, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia
3Auckland Cancer Society Research Centre, Maurice Wilkins Centre for Molecular Biodiscovery, School of Biological Sciences, University of Auckland, Auckland, New Zealand
4Kids Cancer Centre, Sydney Children’s Hospital, Randwick, NSW, Australia

Han Wang1*, Kathy Yuen Yee Chan, PhD2*, Po Yi Lee3*, Chi Zhang2*, Hung Sing LI4*, Wai Man Leung5*, Maxwell Kwok4*, Po Yee Chung2*, Wing Hei Ng, BSc1*, John Tak Kit Cheung1*, Wai Yip Lam6*, Benjamin Li6*, Chi Kong Li7, Ellen Poon8* and Kam Tong Leung2*

1Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong
2Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong
3The Chinese University of Hong Kong, HK, Hong Kong
4The Chinese University of Hong Kong, NT, Hong Kong
5Department of Peadiatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong
6Lee’s Pharmaceutical (HK) Limited, Hong Kong, Hong Kong, Hong Kong
7Department of Paediatrics, The Chinese University of Hong Kong, Shatin, HKG
8The Chinese University of Hong Kong, Hong Kong, Hong Kong

Shiyu Deng1*, Jiawang Ou2*, Cai Zihong3*, Zicong Huang4*, Jia Li1*, Qifa Liu, MD5 and Hongsheng Zhou6*

1Nanfang Hospital, Guangzhou, China
2Southern Medical University, Guangzhou, CHN
3Nanfang Hospital, Southern Medical University,, Guangzhou, CHN
4Southern Medical Unversity, Guangzhou, China
5Department of Hematology, Nanfang Hospital, Southern medical university CN, Guangzhou, China
6Southern Medical University, Guangzhou, China

*signifies non-member of ASH